University of Birmingham, School of Sport, Exercise and Rehabilitation Sciences
Edgbaston, West Midlands, B15 2TT, United Kingdom
NCT Number: NCT04422665
Episodes of inactivity due to hospitalisation, as short as 5 days, are associated with rapid muscle and strength loss in the elderly. The observed muscle loss with inactivity is likely due to muscle anabolic resistance and increased breakdown rates of muscle tissue. This is of great concern as the average hospital stay in the elderly is 5-6 days. Moreover, minor illnesses not requiring hospitalisation generally require short-term periods of inactive home-based recovery. The accumulation of repeated disuse events in older individuals manifests in a chronic muscle anabolic resistance (i.e. the inability of muscle to respond to anabolic stimuli such as exercise and nutrition) that may underpin the slow but devastating process of age-related muscle loss.
It is our belief that strategies to promote muscle health in ageing and reduce healthcare expenditure, should focus on alleviating muscle deterioration and anabolic resistance during short-term disuse.
In this regard, we propose that resistance exercise (i.e. weight lifting) performed prior to a disuse event (termed 'prehabilitation') may be sufficient to offset muscle loss in older individuals. Thus, we suggest the potent effect of resistance exercise in older muscles may prevent muscle loss during short-term disuse.
Looking for future studies?
Notify Me65 year–80 year
Male
Interventional
Not applicable
Edgbaston, West Midlands, B15 2TT, United Kingdom
Participants will be assigned to either single-bout (SINGLE; n=10) or multiple-bouts (MULTI; n=10) of resistance exercise prehabilitation prior to 5 consecutive days of bed rest. Groups will be matched for age, anthropometric characteristics and activity levels. Only males will be studied due to potential gender differences in muscle protein turnover. A single-leg resistance exercise prehabilitation model will allow for a direct within-subject comparison against the non-exercised control leg.
Preliminary Assessments
Following an induction meeting and obtainment of informed consent, participants will report to The National Institute of Health/Wellcome Trust Clinical Research Facility (CRF) at University Hospital Birmingham (UHB) at 0800h having fasted from 2100h the previous night. After measuring height and weight, the following parameters will be determined in the order outlined:
Exercise Prehabilitation (Days 0-7) Participants will be randomly assigned to undergo 4 resistance exercise bouts the week before (Day 1, 2, 5 and 7), or 1 resistance exercise bout on the evening prior to bed rest (i.e. Day 7). Exercise bouts will consist of 8 sets of single-leg knee extension exercise and 8 sets of single-leg leg curls. The non-exercised control leg will remain passive throughout training. Resistance exercise will be performed at 70% of previously determined maximal strength (10-15 repetitions).
Intervention - 5-days of bed-rest (Days 8-13) Participants will report to the CRF at 0700h the morning immediately after exercise prehabilitation phase. At 0800h, muscle biopsies will be obtained from both legs to assess changes in muscle metabolism over the 7 days of prehabilitation. Participants will then be transported for dual energy x-ray absorptiometry (DXA), Magnetic Resonance Imaging (MRI) and ultrasound assessment of body/muscle composition, after which the 5 consecutive days of strict bed rest will begin. The bed rest model will mimic a traditional inpatient hospital stay and reflect the level of muscle unloading that occurs in older individuals following acute illness. Participants will spend the majority of time in bed and will be allowed to adjust the hospital bed head height for reading, eating and watching television, but will otherwise be instructed to lie flat in bed. Bathing/hygiene will be performed in a wheelchair at a sink. The bathroom accessed using a wheelchair. Adherence to bed rest will be monitored by nursing staff and through daily analysis of accelerometry data.
Post Intervention Assessments (Day 13) On the morning after completion of the 5-day bed rest phase (i.e. Day 13) participants will awake at 0700h in the CRF and remain in bed for assessment of muscle protein synthesis in trained and untrained control legs. A cannula will be inserted into a vein of both forearms for frequent blood sampling and a stable isotope tracer infusion. During the tracer infusion, muscle biopsies will be obtained from both trained and untrained legs before and after consumption of a milk protein drink, to assess muscle metabolism. Participants will then be transported by wheelchair for repeat bioelectrical impedance analysis, MRI and ultrasound scans to assess body/muscle composition. Leg strength will be reassessed in trained and untrained legs. A physiotherapist will perform a functional assessment of participants before they are discharged.
Rehabilitation Training Participants will be given the opportunity to complete a 6-week rehabilitation programme, consisting of a progressive 3 x weekly leg resistance training with protein supplementation, designed to fully restore any loss in muscle mass and strength from short-term bed rest. Resistance training rehabilitation will not form a specific study objective, but muscle size and strength will be assessed to ensure restoration of any muscle decline from bed rest.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Single-legged resistance exercise
Time frame: 2 years
Myofibrillar protein synthesis rates will be measured during the prehabilitation and bed rest period in both the exercising and resting leg.
Time frame: 2 years
Muscle volume in the quadriceps will be assessed before and after bed rest using magnetic resonance imaging techniques
Time frame: 2 years
Via immunohistochemical staining procedures muscle fibre cross sectional area will be determined
Time frame: 2 years
Daily average time spent in sedentary, light, moderate or vigorous intensity activity using an accelerometer
Time frame: 2 years
activity will be determined using accelerometry. Furthermore, step count will be Daily step-count assessed using a hip-worn pedometer
Time frame: 2 years
Blood markers - serum total cholesterol, serum high-density lipoprotein cholesterol, serum non-high-density lipoprotein cholesterol, total cholesterol, serum non-esterified fatty acids, serum triglycerides (units of measure for all - mmol/L)
Time frame: 2 years
Via ELISA kits, resting insulin will be assessed using baseline plasma samples from before and after the bed rest period (pmol/l)
Time frame: 2 years
Western blots for phosphorylation of key anabolic and catabolic signaling proteins will be performed.
Time frame: 2 years
Search Results Web results
Reverse transcription polymerase chain reaction (RT-PCR) will be performed to assess gene-expression of muscle anabolic and catabolic genes.
Time frame: 2 years
Dietary intake will be assessed using 3-day weighed food diaries.
Time frame: 2 years
Bioelectrical impedance analysis will be used to determine whole body fat and fat-free mass (units are % of total body mass for both fat and fat-free mass).
Time frame: 2 years
Estimated maximal leg strength will be determined for the leg extension and leg curl before and after the bed rest period
Time frame: 2 years
measured using a stadiometer (cm)
Time frame: 2 years
Measured using a digital weighing scale (kg)
Time frame: 2 years
Weight and height will be combined to report BMI in kg/m^2
University of Birmingham
Other
Exercise 'Prehabilitation': A Novel Intervention to Protect Against Disuse-induced Muscle Atrophy and Sarcopenia in the Old
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05795556
Atrophy, Fall Patients
Copenhagen, Hellerup, Denmark
View Trial DetailsNCT06829121
Atrophy, Muscle Loss
Mainz, Rhineland-Palatinate, Germany
View Trial DetailsNCT05243472
Atrophy, Malnutrition
Hualien City, Taiwan
View Trial DetailsNCT02115698
Atrophy, Frailty
Copenhagen NV, Denmark
View Trial Details